FRANCHINA, Tindara

FRANCHINA, Tindara  

Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva "Gaetano Barresi"  

Mostra records
Risultati 1 - 20 di 88 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. 1-gen-2006 Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. 1-gen-2010 Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 1-gen-2012 Franchina, Tindara; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, Nicola; Agostino, RITA MARIA; Proto, Claudia; Adamo, Vincenzo
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 1-gen-2021 Barbieri, M. A.; Sorbara, E. E.; Cicala, G.; Santoro, V.; Cutroneo, P. M.; Franchina, T.; Spina, E.
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients 1-gen-2015 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 1-gen-2013 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy 1-gen-2017 Lucchesi, Simona; Marciano', Ilaria; Paolo, Panagia; Intelisano, Rosanna; Maria Pia Randazzo, ; Sgroi, Carmela; Altavilla, Giuseppe; Santarpia, Mariacarmela; Adamo, Vincenzo; Franchina, Tindara; Francesco, Ferraù; Paolina, Reitano; Trifiro', Gianluca
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel 1-gen-2018 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V.
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy. 1-gen-2006 Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; Scandurra, G; Scimone, Andrea
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study. 1-gen-2017 Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 1-gen-2016 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo
Challenges and promises of physical exercise in advances lung cancer patients 1-gen-2018 Franchina, T.; Russo, A.; Ricciardi, G. R. R.; Righi, M.; Franchina, V.; Adamo, V.; Magaudda, L.
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy 1-gen-2018 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Toscano, G.; Schifano, S.; Lo Certo, G.; Battaglia, A.; Panto', E.; Scaffidi Fonti, M.; Adamo, V.
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. 1-gen-2014 Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V.
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. 1-gen-2012 Gangemi, Sebastiano; Minciullo, PAOLA LUCIA; Adamo, Barbara; Franchina, Tindara; Ricciardi, GIUSEPPINA ROSARIA; Ferraro, M; Briguglio, Roberta; Toscano, G; Saitta, Salvatore; Adamo, Vincenzo
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 1-gen-2016 Bronte, Giuseppe; Franchina, Tindara; Alù, Massimiliano; Sortino, Giovanni; Celesia, Claudia; Passiglia, Francesco; Savio, Giuseppina; Laudani, Agata; Russo, Alessandro; Picone, Antonio; Rizzo, Sergio; De Tursi, Michele; Gambale, Elisabetta; Bazan, Viviana; Natoli, Clara; Blasi, Livio; Adamo, Vincenzo; Russo, Antonio
Correction: Androgen Receptor (AR), E-cadherin, and Ki-67 as emerging targets and novel prognostic markers in Triple-Negative Breast Cancer (TNBC) patients 1-gen-2015 Ricciardi, Giuseppina Rosaria Rita; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 1-gen-2015 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 1-gen-2020 Passiglia, F.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases 1-gen-2015 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Adamo, Vincenzo